Literature DB >> 6281083

Calcium: calmodulin and cancer.

W E Criss, S Kakiuchi.   

Abstract

When several fast-growing Morris hepatoma tissue lines are compared with normal adult liver tissue, the following observations are made: calmodulin activity is increased in the cytoplasm and decreased in the membrane of the tumor cells. Total calcium is increased three- to fivefold in the tumors. Cyclic AMP phosphodiesterase activity is increased, whereas cyclic GMP phosphodiesterase activity is decreased. In addition, several of the fast-growing Morris hepatoma tissue lines have a new calcium-binding protein that is not observed in adult liver tissue. It is probable that the Ca2+-calmodulin complex is very active in these rapidly growing tumors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281083

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  12 in total

1.  Altered coupling states between calcium transport and (Ca2+, Mg2+)-ATPase in the AS-30D ascites hepatocarcinoma plasma membrane.

Authors:  J Mas-Oliva; R Pérez-Montfort; M Cárdenas-García; M Rivas-Duro
Journal:  Mol Cell Biochem       Date:  1991-01-16       Impact factor: 3.396

Review 2.  Calcium, cyclic AMP and protein kinase C--partners in mitogenesis.

Authors:  J F Whitfield; J P Durkin; D J Franks; L P Kleine; L Raptis; R H Rixon; M Sikorska; P R Walker
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Conformational changes induced by binding of bivalent cations to oncomodulin, a paravalbumin-like tumour protein.

Authors:  J P MacManus; A G Szabo; R E Williams
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

4.  Inhibition of metabolic cooperation in Chinese hamster lung fibroblast cells (V79) in culture by various DDT-analogs.

Authors:  L Wärngård; S Flodström; S Ljungquist; U G Ahlborg
Journal:  Arch Environ Contam Toxicol       Date:  1985-09       Impact factor: 2.804

5.  Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancer.

Authors:  Daniel R Principe; Alexandre F Aissa; Sandeep Kumar; Thao N D Pham; Patrick W Underwood; Rakesh Nair; Rong Ke; Basabi Rana; Jose G Trevino; Hidayatullah G Munshi; Elizaveta V Benevolenskaya; Ajay Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-27       Impact factor: 12.779

6.  Calcium-binding proteins in human carcinoma cell lines.

Authors:  G E Pfyffer; G Haemmerli; C W Heizmann
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

7.  Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes.

Authors:  S Batra
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Inhibition of human breast cancer colony formation by anticalmodulin agents: trifluoperazine, W-7, and W-13.

Authors:  J W Wei; R A Hickie; D J Klaassen
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Calmodulin content in human central nervous system tumors.

Authors:  A J Bridges; A K Ho
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

10.  Characterization of 83-kilodalton nonmuscle caldesmon from cultured rat cells: stimulation of actin binding of nonmuscle tropomyosin and periodic localization along microfilaments like tropomyosin.

Authors:  S Yamashiro-Matsumura; F Matsumura
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.